Deals
Geron sells last drug in pipeline to J&J unit
Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.
Hachette and Amazon reach agreement on e-book sales
Hachette Book Group and Amazon.com Inc said on Thursday they reached a multi-year agreement for e-book and print book sales after months of bitter fighting that pitted writers and publishers against the world's largest online retail store.
Virtu aiming for spring 2015 IPO - sources
Electronic trading company Virtu Financial LLC hopes to go public in the spring, about a year after it originally planned its market debut, two sources familiar with the matter said on Thursday.
Scuttled deals worth $580 billion put hedge funds on back foot
Hedge funds specializing in bets on mergers and acquisitions are starting to see investors withdraw funds, prompting them to take a more cautious approach after being caught out by more than 500 corporate deals globally failing this year.